Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
p53-Mediated Growth Suppression Enhanced By Chemotherapy
May 6th, 2000
Wild-type p53 gene-transfer-mediated growth suppression of human ovarian carcinoma can be enhanced by chemotherapy. "The aim of this work was to observe the growth and chemosensitivity of human ovarian cancer OV-MZ-2a and OV-MZ-32 cells following adenovirus-based wild-type p53 (Ad-p53) gene transfer alone or combined with chemotherapeutic agents," wrote Q. Wu and colleagues, State University of New York, USA. Wu et al. published their study in the Journal of Cancer Research and Clinical Oncology ("Growth suppression of human ovarian carcinoma OV-MZ-2a and OV-MZ-32 cells mediated by gene transfer of wild-type p53 enhanced by chemotherapy in...
Source: Women's Health Weekly (2000-05-06)
|
